Neurocrine Biosciences (NBIX) Receivables - Net: 2010-2021
Historic Receivables - Net for Neurocrine Biosciences (NBIX) over the last 8 years, with Sep 2021 value amounting to $163.8 million.
- Neurocrine Biosciences' Receivables - Net rose 4.40% to $163.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $163.8 million, marking a year-over-year increase of 4.40%. This contributed to the annual value of $157.1 million for FY2020, which is 24.09% up from last year.
- According to the latest figures from Q3 2021, Neurocrine Biosciences' Receivables - Net is $163.8 million, which was up 3.34% from $158.5 million recorded in Q2 2021.
- In the past 5 years, Neurocrine Biosciences' Receivables - Net registered a high of $163.8 million during Q3 2021, and its lowest value of $6.1 million during Q2 2017.
- Over the past 3 years, Neurocrine Biosciences' median Receivables - Net value was $148.4 million (recorded in 2020), while the average stood at $135.5 million.
- In the last 5 years, Neurocrine Biosciences' Receivables - Net skyrocketed by 602.11% in 2018 and then fell by 0.54% in 2021.
- Neurocrine Biosciences' Receivables - Net (Quarterly) stood at $31.1 million in 2017, then skyrocketed by 84.43% to $57.4 million in 2018, then soared by 120.53% to $126.6 million in 2019, then climbed by 24.09% to $157.1 million in 2020, then grew by 4.40% to $163.8 million in 2021.
- Its Receivables - Net was $163.8 million in Q3 2021, compared to $158.5 million in Q2 2021 and $147.8 million in Q1 2021.